A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Clinical trial NCT05662020 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05662020
- Sponsor
- Beijing Health Guard Biotechnology, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2022-11-07
- Enrollment
- 2750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.